Similar Survival Between Haploidentical T-Cell Replete Hematopoietic Transplantation (Haplo) with Post-Transplantation Cyclophosphamide (PT-CY) and Unrelated Cord Blood Transplant (UCBT) in Chile

被引：0
|
作者：
Sanchez, Matias E. [1 ]
Negrete, Francisca [1 ]
Mosso, Claudio [2 ]
Morales, Romina [1 ]
Maureira, Karina [1 ]
Bertin, Pablo [3 ]
Diaz, Javier [3 ]
Jara, Veronica [3 ]
Carvallo, Cristian [1 ]
Ramirez, Pablo A. [3 ]
机构：
[1] Clin Santa Maria, Dept Hematol & Oncol, Santiago, Chile
[2] Clin Santa Maria, Dept Pediat Hematol Oncol, Santiago, Chile
[3] Pontifical Catholic Univ, Hematol Oncol, Santiago, Chile
来源：
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION | 2016年 / 22卷 / 03期
关键词：
D O I：
10.1016/j.bbmt.2015.11.889
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
566
引用
收藏
页码：S376 / S377
页数：2
相关论文
共 50 条
  • [41] HAPLOIDENTICAL STEM CELL TRANSPLANTATION (HAPLO-HSCT) WITH HIGH DOSE CYLOPHOSPHAMIDE POST-TRANSPLANT (PT-CY) AS GVHD PROPHYLAXIS IN HIGH RISK HEMATOLOGIC
    Gayoso, J.
    Balsalobre, P.
    Kwon, M.
    Jesus Pascual, M.
    Castilla, C.
    Serrano, D.
    Lopez-Corral, L.
    Antonio Perez-Simon, J.
    Bermudez, A.
    Rovira, M.
    Perez-Corral, A.
    Anguita, J.
    Heras, I.
    Solano, C.
    Figuera, A.
    Antonia Sampol, M.
    Ferra, C.
    Herrera, P.
    Sonia Gonzalez, M.
    Montesinos, P.
    Buno, I.
    Luis Diez-Martin, J.
    [J]. BONE MARROW TRANSPLANTATION, 2014, 49 : S280 - S280
  • [42] Disease Risk Index Is the Major Predictor of Outcome Following Myeloablative Haploidentical Hematopoietic Stem Cell Transplantation (haplo-HSCT) and Post-Transplant Cyclophosphamide (PT/Cy)
    Solomon, Scott R.
    Sizemore, Connie
    Zhang, Xu
    Solh, Melhem
    Morris, Lawrence E.
    Holland, H. Kent
    Bashey, Asad
    [J]. BLOOD, 2015, 126 (23)
  • [43] Immune reconstitution after T-cell replete HLA haploidentical hematopoietic stem cell transplantation using high-dose post-transplant cyclophosphamide
    Maeda, Yoshinobu
    [J]. JOURNAL OF CLINICAL AND EXPERIMENTAL HEMATOPATHOLOGY, 2021, 61 (01) : 1 - 9
  • [44] T-Cell-Replete HLA-Haploidentical Hematopoietic Transplantation for Hematologic Malignancies Using Post-Transplantation Cyclophosphamide Results in Outcomes Equivalent to Those of Contemporaneous HLA-Matched Related and Unrelated Donor Transplantation
    Bashey, Asad
    Zhang, Xu
    Sizemore, Connie A.
    Manion, Karen
    Brown, Stacey
    Holland, H. Kent
    Morris, Lawrence E.
    Solomon, Scott R.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (10) : 1310 - 1316
  • [45] Use of G-CSF mobilized bone marrow grafts in HLA-haploidentical related bone marrow transplantation (BMT) with post-transplantation cyclophosphamide (PT-CY)
    Nadira, D.
    Brian, M. J.
    Zinaida, P.
    Lana, D.
    Alen, O.
    Zorana, G.
    Ranka, S. S.
    Radovan, V.
    [J]. BONE MARROW TRANSPLANTATION, 2017, 52 : S147 - S148
  • [46] Cytomegalovirus (CMV) disease in peripheral blood (PB) allogeneic hematopoietic cell transplant (HCT) with post transplant cyclophosphamide (PT-Cy).
    Goldsmith, Scott Ryan
    Slade, Michael
    Lawrence, Steven J.
    Romee, Rizwan
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [47] Post-Transplant Cyclophosphamide (PT-Cy) Based Haploidentical Cell Transplantation (Haplo) Versus Rabbit Anti-Thymocyte Globulin (r-ATG) Based HLA Matched Unrelated Donor (MUD) Transplantation in Patients (pts) with Relapsed/Refractory Lymphoma
    Mukherjee, Akash
    Milton, Denai R.
    Gulbis, Alison
    Ledesma, Celina
    Jabbour, Elias
    Alousi, Amin M.
    Bashir, Qaiser
    Daher, May
    Oran, Betul
    Olson, Amanda L.
    Marin, David
    Srour, Samer
    Kebriaei, Partow
    Mehta, Rohtesh S.
    Nemeth, Kathie P.
    Popat, Uday
    Im, Jin S.
    Champlin, Richard E.
    Khouri, Issa F.
    [J]. BLOOD, 2019, 134
  • [48] Immunosuppression Free at One-Year Post Haploidentical Hematopoietic Cell Transplantation (Haplo) with Post-Transplant Cyclophosphamide (PTCY)
    Solh, Melhem M.
    Solomon, Scott R.
    Morris, Lawrence
    Bachier-Rodriguez, Lizamarie
    Holland, H. Kent
    Zhang, Xu
    Jackson, Katelin C.
    Bashey, Asad
    [J]. BLOOD, 2023, 142
  • [49] Progressive multifocal leukoencephalopathy after T-cell replete HLA-haploidentical transplantation with post-transplantation cyclophosphamide graft-versus-host disease prophylaxis
    Ikegawa, Shuntaro
    Fujii, Nobuharu
    Tadokoro, Koh
    Sato, Kota
    Iwamoto, Miki
    Matsuda, Masayuki
    Inomata, Tomoko
    Sugiura, Hiroyuki
    Asano, Takeru
    Yoshida, Shohei
    Nishimori, Hisakazu
    Matsuoka, Ken-ichi
    Maeda, Yoshinobu
    [J]. TRANSPLANT INFECTIOUS DISEASE, 2018, 20 (02)
  • [50] Haploidentical Stem Cell Transplantation (HAPLO-HSCT) with Post-Transplant Cyclophosphamide (PT-CY) As Gvhd Prophylaxis in High Risk Hematologic Malignancies: Bone Marrow or Peripheral Blood Progenitors Render Same Results
    Gayoso, Jorge
    Balsalobre, Pascual
    Kwon, Mi
    Castilla-Llorente, Cristina
    Jesus Pascual, Maria
    Lopez-Corral, Lucia
    Luis Pinana, Jose
    Bermudez, Arancha
    Antonio Perez-Simon, Jose
    Herrera, Pilar
    Montesinos, Pau
    Ferra, Christelle
    Sampol, Antonia
    Anguita, Javier
    Heras, Inmaculada
    Champ, Diana
    Martinez-Laperche, Carolina
    Solano, Carlos
    Caballero, Dolores
    Luis Diez-Martin, Jose
    [J]. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2015, 21 (02) : S284 - S284
12345